Eli Gilboa

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Physiology

Anatomy

Chemicals & Drugs

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Dollins Claudia M; Nair Smita; Boczkowski David; Lee Jaewoo; Layzer Juliana M; Gilboa Eli; Sullenger Bruce A
Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.
McNamara James O; Kolonias Despina; Pastor Fernando; Mittler Robert S; Chen Lieping; Giangrande Paloma H; Sullenger Bruce; Gilboa Eli
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice.
Melhem Nada M; Liu Xiang Dong; Boczkowski David; Gilboa Eli; Barratt-Boyes Simon M
Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Eli Gilboa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Dollins Claudia M; Nair Smita; Boczkowski David; Lee Jaewoo; Layzer Juliana M; Gilboa Eli; Sullenger Bruce A
Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.
Chemistry & biology 2008;15(7):675-82.
2008: McNamara James O; Kolonias Despina; Pastor Fernando; Mittler Robert S; Chen Lieping; Giangrande Paloma H; Sullenger Bruce; Gilboa Eli
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice.
The Journal of clinical investigation 2008;118(1):376-86.
2007: Melhem Nada M; Liu Xiang Dong; Boczkowski David; Gilboa Eli; Barratt-Boyes Simon M
Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag.
European journal of immunology 2007;37(8):2164-73.
2007: Gilboa Eli
DC-based cancer vaccines.
The Journal of clinical investigation 2007;117(5):1195-203.
2007: Nair Smita; Boczkowski David; Fassnacht Martin; Pisetsky David; Gilboa Eli
Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity.
Cancer research 2007;67(1):371-80.
2006: McNamara James O; Andrechek Eran R; Wang Yong; Viles Kristi D; Rempel Rachel E; Gilboa Eli; Sullenger Bruce A; Giangrande Paloma H
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.
Nature biotechnology 2006;24(8):1005-15.
2006: Fecci Peter E; Sweeney Alison E; Grossi Peter M; Nair Smita K; Learn Christopher A; Mitchell Duane A; Cui Xiuyu; Cummings Thomas J; Bigner Darell D; Gilboa Eli; Sampson John H
Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4294-305.
2006: Hess Paul R; Boczkowski David; Nair Smita K; Snyder David; Gilboa Eli
Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen.
Cancer immunology, immunotherapy : CII 2006;55(6):672-83.
2006: Kavanagh Daniel G; Kaufmann Daniel E; Sunderji Sherzana; Frahm Nicole; Le Gall Sylvie; Boczkowski David; Rosenberg Eric S; Stone David R; Johnston Mary N; Wagner Bradford S; Zaman Mohammad T; Brander Christian; Gilboa Eli; Walker Bruce D; Bhardwaj Nina
Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef.
Blood 2006;107(5):1963-9.
2005: Lee Jaewoo; Fassnacht Martin; Nair Smita; Boczkowski David; Gilboa Eli
Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
Cancer research 2005;65(23):11156-63.
2005: Dannull Jens; Su Zhen; Rizzieri David; Yang Benjamin K; Coleman Doris; Yancey Donna; Zhang Aijing; Dahm Philipp; Chao Nelson; Gilboa Eli; Vieweg Johannes
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.
The Journal of clinical investigation 2005;115(12):3623-33.
2005: Fassnacht Martin; Lee Jaewoo; Milazzo Caterina; Boczkowski David; Su Zhen; Nair Smita; Gilboa Eli
Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(15):5566-71.
2005: Dannull Jens; Nair Smita; Su Zhen; Boczkowski David; DeBeck Christian; Yang Benjamin; Gilboa Eli; Vieweg Johannes
Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand.
Blood 2005;105(8):3206-13.
2005: Su Zhen; Dannull Jens; Yang Benjamin K; Dahm Philipp; Coleman Doris; Yancey Donna; Sichi Sylvia; Niedzwiecki Donna; Boczkowski David; Gilboa Eli; Vieweg Johannes
Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(6):3798-807.
2004: Gilboa Eli
Knocking the SOCS1 off dendritic cells.
Nature biotechnology 2004;22(12):1521-2.
2004: Gilboa Eli; Vieweg Johannes
Cancer immunotherapy with mRNA-transfected dendritic cells.
Immunological reviews 2004;199():251-63.
2004: Cisco Robin M; Abdel-Wahab Zeinab; Dannull Jens; Nair Smita; Tyler Douglas S; Gilboa Eli; Vieweg Johannes; Daaka Yehia; Pruitt Scott K
Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(11):7162-8.
2004: Gilboa Eli
The promise of cancer vaccines.
Nature reviews. Cancer 2004;4(5):401-11.
2004: Liao Xinsheng; Li Yongqing; Bonini Chiara; Nair Smita; Gilboa Eli; Greenberg Philip D; Yee Cassian
Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(5):757-64.
2003: Nair Smita; McLaughlin Catherine; Weizer Alon; Su Zhen; Boczkowski David; Dannull Jens; Vieweg Johannes; Gilboa Eli
Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(11):6275-82.
2003: Zhao Yangbing; Boczkowski David; Nair Smita K; Gilboa Eli
Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity.
Blood 2003;102(12):4137-42.
2003: Santulli-Marotto Sandra; Nair Smita K; Rusconi Chris; Sullenger Bruce; Gilboa Eli
Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity.
Cancer research 2003;63(21):7483-9.
2003: Nair Smita; Boczkowski David; Moeller Benjamin; Dewhirst Mark; Vieweg Johannes; Gilboa Eli
Synergy between tumor immunotherapy and antiangiogenic therapy.
Blood 2003;102(3):964-71.
2003: Morse Michael A; Nair Smita K; Mosca Paul J; Hobeika Amy C; Clay Timothy M; Deng Yuping; Boczkowski David; Proia Alan; Neidzwiecki Donna; Clavien Pierre-A; Hurwitz Herbert I; Schlom Jeffrey; Gilboa Eli; Lyerly H Kim
Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA.
Cancer investigation 2003;21(3):341-9.
2003: Su Zhen; Dannull Jens; Heiser Axel; Yancey Donna; Pruitt Scott; Madden John; Coleman Doris; Niedzwiecki Donna; Gilboa Eli; Vieweg Johannes
Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells.
Cancer research 2003;63(9):2127-33.
2002: Su Zhen; Vieweg Johannes; Weizer Alon Z; Dahm Philipp; Yancey Donna; Turaga Vandana; Higgins John; Boczkowski David; Gilboa Eli; Dannull Jens
Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product.
Cancer research 2002;62(17):5041-8.
2002: Sullenger Bruce A; Gilboa Eli
Emerging clinical applications of RNA.
Nature 2002;418(6894):252-8.
2002: Nair Smita K; Morse Michael; Boczkowski David; Cumming R Ian; Vasovic Ljiljana; Gilboa Eli; Lyerly H Kim
Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells.
Annals of surgery 2002;235(4):540-9.
2002: Heiser Axel; Coleman Doris; Dannull Jens; Yancey Donna; Maurice Margaret A; Lallas Costas D; Dahm Philipp; Niedzwiecki Donna; Gilboa Eli; Vieweg Johannes
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors.
The Journal of clinical investigation 2002;109(3):409-17.
2002: Faiola Brenda; Doyle Carolyn; Gilboa Eli; Nair Smita
Influence of CD4 T cells and the source of major histocompatibility complex class II-restricted peptides on cytotoxic T-cell priming by dendritic cells.
Immunology 2002;105(1):47-55.
2002: Morse Michael A; Nair Smita K; Boczkowski David; Tyler Douglas; Hurwitz Herbert I; Proia Alan; Clay Timothy M; Schlom Jeffrey; Gilboa Eli; Lyerly H Kim
The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer.
International journal of gastrointestinal cancer 2002;32(1):1-6.
2001: Gilboa E
The risk of autoimmunity associated with tumor immunotherapy.
Nature immunology 2001;2(9):789-92.
2001: Nishimura Ji; Phillips K L; Ware R E; Hall S; Wilson L; Gentry T L; Howard T A; Murakami Y; Shibano M; Machii T; Gilboa E; Kanakura Y; Takeda J; Kinoshita T; Rosse W F; Smith C A
Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype.
Blood 2001;97(10):3004-10.
2001: Heiser A; Maurice M A; Yancey D R; Wu N Z; Dahm P; Pruitt S K; Boczkowski D; Nair S K; Ballo M S; Gilboa E; Vieweg J
Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(5):2953-60.
2000: Nair S K; Heiser A; Boczkowski D; Majumdar A; Naoe M; Lebkowski J S; Vieweg J; Gilboa E
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
Nature medicine 2000;6(9):1011-7.
2000: Kodaira Y; Nair S K; Wrenshall L E; Gilboa E; Platt J L
Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(3):1599-604.
2000: Thornburg C; Boczkowski D; Gilboa E; Nair S K
Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(4):412-8.
2000: Larchian W A; Horiguchi Y; Nair S K; Fair W R; Heston W D; Gilboa E
Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2913-20.
2000: Heiser A; Dahm P; Yancey D R; Maurice M A; Boczkowski D; Nair S K; Gilboa E; Vieweg J
Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(10):5508-14.
2000: Boczkowski D; Nair S K; Nam J H; Lyerly H K; Gilboa E
Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells.
Cancer research 2000;60(4):1028-34.
1999: Gilboa E
How tumors escape immune destruction and what we can do about it.
Cancer immunology, immunotherapy : CII 1999;48(7):382-5.
1999: Gilboa E
The makings of a tumor rejection antigen.
Immunity 1999;11(3):263-70.
1999: Nair S K; Hull S; Coleman D; Gilboa E; Lyerly H K; Morse M A
Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA.
International journal of cancer. Journal international du cancer 1999;82(1):121-4.
1999: Nair S; Wearsch P A; Mitchell D A; Wassenberg J J; Gilboa E; Nicchitta C V
Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(11):6426-32.
1998: Morse M A; Lyerly H K; Gilboa E; Thomas E; Nair S K
Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells.
Cancer research 1998;58(14):2965-8.
1998: Mitchell D A; Nair S K; Gilboa E
Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells.
European journal of immunology 1998;28(6):1923-33.
1998: Lee S W; Gilboa E
High level accumulation of an aberrantly spliced human DHFR RNA species.
Molecules and cells 1998;8(2):189-200.
1998: Gilboa E; Nair S K; Lyerly H K
Immunotherapy of cancer with dendritic-cell-based vaccines.
Cancer immunology, immunotherapy : CII 1998;46(2):82-7.
1998: Nair S K; Boczkowski D; Morse M; Cumming R I; Lyerly H K; Gilboa E
Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.
Nature biotechnology 1998;16(4):364-9.
1998: McCowage G B; Phillips K L; Gentry T L; Hull S; Kurtzberg J; Gilboa E; Smith C
Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells.
Experimental hematology 1998;26(4):288-98.
1997: Ashley D M; Faiola B; Nair S; Hale L P; Bigner D D; Gilboa E
Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors.
The Journal of experimental medicine 1997;186(7):1177-82.
1997: Nair S K; Snyder D; Rouse B T; Gilboa E
Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts.
International journal of cancer. Journal international du cancer 1997;70(6):706-15.
1997: Clary B M; Coveney E C; Philip R; Blazer D G; Morse M; Gilboa E; Lyerly H K
Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.
Cancer gene therapy 1997;4(2):97-104.
1997: Nair S K; Boczkowski D; Snyder D; Gilboa E
Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines.
European journal of immunology 1997;27(3):589-97.
1997: Clary B M; Coveney E C; Blazer D G; Philip R; Philip M; Morse M; Gilboa E; Lyerly H K
Active immunization with tumor cells transduced by a novel AAV plasmid-based gene delivery system.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(1):26-37.
1997: Porgador A; Staats H F; Faiola B; Gilboa E; Palker T J
Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(2):834-41.
1996: Smith C; Lee S W; Wong E; Gallardo H; Page K; Gaspar O; Lebkowski J; Gilboa E
Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys.
Antiviral research 1996;32(2):99-115.
1996: Phillips K; Gentry T; McCowage G; Gilboa E; Smith C
Cell-surface markers for assessing gene transfer into human hematopoietic cells.
Nature medicine 1996;2(10):1154-6.
1996: Rudoll T; Phillips K; Lee S W; Hull S; Gaspar O; Sucgang N; Gilboa E; Smith C
High-efficiency retroviral vector mediated gene transfer into human peripheral blood CD4+ T lymphocytes.
Gene therapy 1996;3(8):695-705.
1996: Boczkowski D; Nair S K; Snyder D; Gilboa E
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
The Journal of experimental medicine 1996;184(2):465-72.
1996: Porgador A; Snyder D; Gilboa E
Induction of antitumor immunity using bone marrow-generated dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(8):2918-26.
1996: Nair S K; Snyder D; Gilboa E
Cells treated with TAP-2 antisense oligonucleotides are potent antigen-presenting cells in vitro and in vivo.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(5):1772-80.
1996: Gilboa E
Immunotherapy of cancer with genetically modified tumor vaccines.
Seminars in oncology 1996;23(1):101-7.
1995: Lee S W; Gallardo H F; Gaspar O; Smith C; Gilboa E
Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
Gene therapy 1995;2(6):377-84.
1995: Porgador A; Gilboa E
Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
The Journal of experimental medicine 1995;182(1):255-60.
1995: Vieweg J; Boczkowski D; Roberson K M; Edwards D W; Philip M; Philip R; Rudoll T; Smith C; Robertson C; Gilboa E
Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer.
Cancer research 1995;55(11):2366-72.
1995: Tjuvajev J; Gansbacher B; Desai R; Beattie B; Kaplitt M; Matei C; Koutcher J; Gilboa E; Blasberg R
RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.
Cancer research 1995;55(9):1902-10.
1995: Vieweg J; Gilboa E
Gene therapy approaches in urologic oncology.
Surgical oncology clinics of North America 1995;4(2):203-18.
1995: Vieweg J; Gilboa E
Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment.
Cancer investigation 1995;13(2):193-201.
1994: Lee S W; Gallardo H F; Gilboa E; Smith C
Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Journal of virology 1994;68(12):8254-64.
1994: Gilboa E; Lyerly H K; Vieweg J; Saito S
Immunotherapy of cancer using cytokine gene-modified tumor vaccines.
Seminars in cancer biology 1994;5(6):409-17.
1994: Saito S; Bannerji R; Gansbacher B; Rosenthal F M; Romanenko P; Heston W D; Fair W R; Gilboa E
Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines.
Cancer research 1994;54(13):3516-20.
1994: Vieweg J; Heston W D; Gilboa E; Fair W R
An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer.
The Prostate 1994;24(6):291-8.
1994: Li M X; Banerjee D; Zhao S C; Schweitzer B I; Mineishi S; Gilboa E; Bertino J R
Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction.
Blood 1994;83(11):3403-8.
1994: Vieweg J; Rosenthal F M; Bannerji R; Heston W D; Fair W R; Gansbacher B; Gilboa E
Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.
Cancer research 1994;54(7):1760-5.
1994: Gilboa E; Smith C
Gene therapy for infectious diseases: the AIDS model.
Trends in genetics : TIG 1994;10(4):139-44.
1994: Bannerji R; Arroyo C D; Cordon-Cardo C; Gilboa E
The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(5):2324-32.
1994: Zhao S C; Li M X; Banerjee D; Schweitzer B I; Mineishi S; Gilboa E; Bertino J R
Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase.
Cancer gene therapy 1994;1(1):27-33.
1993: Chen L L; Gansbacher B; Gilboa E; Taetle R; Oval J; Hibbs M S; Huang C K; Clawson M L; Bilgrami S; Schlessinger J
Retroviral gene transfer of epidermal growth factor receptor into HL60 cells results in a partial block of retinoic acid-induced granulocytic differentiation.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(9):769-76.
1993: Bordignon C; Mavilio F; Ferrari G; Servida P; Ugazio A G; Notarangelo L D; Gilboa E; Rossini S; O'Reilly R J; Smith C A
Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID.
Human gene therapy 1993;4(4):513-20.
1993: Connor J; Bannerji R; Saito S; Heston W; Fair W; Gilboa E
Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.
The Journal of experimental medicine 1993;177(4):1127-34.
1993: Porgador A; Bannerji R; Watanabe Y; Feldman M; Gilboa E; Eisenbach L
Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(4):1458-70.
1993: Porgador A; Gansbacher B; Bannerji R; Tzehoval E; Gilboa E; Feldman M; Eisenbach L
Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells.
International journal of cancer. Journal international du cancer 1993;53(3):471-7.
1993: Smith C; Muench M O; Knizewski M; Gilboa E; Moore M A
Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in-vivo model of acute non-lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(2):310-7.
1992: Gansbacher B; Zier K; Cronin K; Hantzopoulos P A; Bouchard B; Houghton A; Gilboa E; Golde D
Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells.
Blood 1992;80(11):2817-25.
1992: Gastl G; Finstad C L; Guarini A; Bosl G; Gilboa E; Bander N H; Gansbacher B
Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.
Cancer research 1992;52(22):6229-36.
1992: Li M; Hantzopoulos P A; Banerjee D; Zhao S C; Schweitzer B I; Gilboa E; Bertino J R
Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors.
Human gene therapy 1992;3(4):381-90.
1992: Suchi M; Dinur T; Desnick R J; Gatt S; Pereira L; Gilboa E; Schuchman E H
Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: correction of the metabolic defect in cultured Niemann-Pick disease cells.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(8):3227-31.
1992: Lee T C; Sullenger B A; Gallardo H F; Ungers G E; Gilboa E
Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells.
The New biologist 1992;4(1):66-74.
1991: Sullenger B A; Gallardo H F; Ungers G E; Gilboa E
Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation.
Journal of virology 1991;65(12):6811-6.
1991: Fetten J V; Roy N; Gilboa E
A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(8):2697-705.
1991: Ferrari G; Rossini S; Giavazzi R; Maggioni D; Nobili N; Soldati M; Ungers G; Mavilio F; Gilboa E; Bordignon C
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency.
Science (New York, N.Y.) 1991;251(4999):1363-6.
1991: Oval J; Hershberg R; Gansbacher B; Gilboa E; Schlessinger J; Taetle R
Expression of functional epidermal growth factor receptors in a human hematopoietic cell line.
Cancer research 1991;51(1):150-6.
1990: Sullenger B A; Lee T C; Smith C A; Ungers G E; Gilboa E
Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication.
Molecular and cellular biology 1990;10(12):6512-23.
1990: Gansbacher B; Bannerji R; Daniels B; Zier K; Cronin K; Gilboa E
Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.
Cancer research 1990;50(24):7820-5.
1990: Sullenger B A; Gallardo H F; Ungers G E; Gilboa E
Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication.
Cell 1990;63(3):601-8.
1990: Gansbacher B; Zier K; Daniels B; Cronin K; Bannerji R; Gilboa E
Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.
The Journal of experimental medicine 1990;172(4):1217-24.
1990: Wolfe J H; Schuchman E H; Stramm L E; Concaugh E A; Haskins M E; Aguirre G D; Patterson D F; Desnick R J; Gilboa E
Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(8):2877-81.
1990: Gilboa E
Retroviral gene transfer: applications to human therapy.
Progress in clinical and biological research 1990;352():301-11.
1989: Bordignon C; Yu S F; Smith C A; Hantzopoulos P; Ungers G E; Keever C A; O'Reilly R J; Gilboa E
Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(17):6748-52.
1989: Hantzopoulos P A; Sullenger B A; Ungers G; Gilboa E
Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(10):3519-23.
1989: Kantoff P W; Flake A W; Eglitis M A; Scharf S; Bond S; Gilboa E; Erlich H; Harrison M R; Zanjani E D; Anderson W F
In utero gene transfer and expression: a sheep transplantation model.
Blood 1989;73(4):1066-73.
1989: von Rüden T; Gilboa E
Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA.
Journal of virology 1989;63(2):677-82.
1988: Hwang L H; Gilboa E
Intron sequences may influence the efficiency and correctness in selecting a 3'-splicing acceptor site.
Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association 1988;87(12):1141-8.
1988: Gilboa E
Retroviral gene transfer: applications to human therapy.
Advances in experimental medicine and biology 1988;241():29-33.
1987: Rasmussen J A; Gilboa E
Significance of DNase I-hypersensitive sites in the long terminal repeats of a Moloney murine leukemia virus vector.
Journal of virology 1987;61(5):1368-74.
1987: Armentano D; Yu S F; Kantoff P W; von Ruden T; Anderson W F; Gilboa E
Effect of internal viral sequences on the utility of retroviral vectors.
Journal of virology 1987;61(5):1647-50.
1986: Gilboa E
Retrovirus vectors and their uses in molecular biology.
BioEssays : news and reviews in molecular, cellular and developmental biology 1986;5(6):252-7.
1986: Yu S F; von Rüden T; Kantoff P W; Garber C; Seiberg M; Rüther U; Anderson W F; Wagner E F; Gilboa E
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(10):3194-8.
1986: Wolff L; Mushinski J F; Gilboa E; Morse H C
Induction of hematopoietic tumors using a viral construct containing c-myc cDNA from normal mouse spleen.
Current topics in microbiology and immunology 1986;132():33-9.
1986: Anderson W F; Kantoff P W; Eglitis M A; Gilboa E
Gene transfer into animals by retroviral vectors.
Basic life sciences 1986;37():59-65.
1985: Eglitis M A; Kantoff P; Gilboa E; Anderson W F
Gene expression in mice after high efficiency retroviral-mediated gene transfer.
Science (New York, N.Y.) 1985;230(4732):1395-8.
1985: Keller G; Paige C; Gilboa E; Wagner E F
Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors.
Nature 1985;318(6042):149-54.
1985: Taketo M; Gilboa E; Sherman M I
Isolation of embryonal carcinoma cell lines that express integrated recombinant genes flanked by the Moloney murine leukemia virus long terminal repeat.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(8):2422-6.
1985: Wagner E F; Keller G; Gilboa E; Rüther U; Stewart C
Gene transfer into murine stem cells and mice using retroviral vectors.
Cold Spring Harbor symposia on quantitative biology 1985;50():691-700.
1984: Hwang L S; Park J; Gilboa E
Role of intron-contained sequences in formation of moloney murine leukemia virus env mRNA.
Molecular and cellular biology 1984;4(11):2289-97.
1984: Hwang L H; Gilboa E
Expression of genes introduced into cells by retroviral infection is more efficient than that of genes introduced into cells by DNA transfection.
Journal of virology 1984;50(2):417-24.
1984: Champoux J J; Gilboa E; Baltimore D
Mechanism of RNA primer removal by the RNase H activity of avian myeloblastosis virus reverse transcriptase.
Journal of virology 1984;49(3):686-91.
1982: Gilboa E; Kolbe M; Noonan K; Kucherlapati R
Construction of a mammalian transducing vector from the genome of Moloney murine leukemia virus.
Journal of virology 1982;44(3):845-51.
1981: Goff S P; Witte O N; Gilboa E; Rosenberg N; Baltimore D
Genome structure of Abelson murine leukemia virus variants: proviruses in fibroblasts and lymphoid cells.
Journal of virology 1981;38(2):460-8.
1981: Shoemaker C; Goff S; Gilboa E; Paskind M; Mitra S W; Baltimore D
Structure of cloned retroviral circular DNAs: implications for virus integration.
Cold Spring Harbor symposia on quantitative biology 1981;45 Pt 2():711-7.
1980: Goff S P; Gilboa E; Witte O N; Baltimore D
Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA.
Cell 1980;22(3):777-85.
1980: Shoemaker C; Goff S; Gilboa E; Paskind M; Mitra S W; Baltimore D
Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(7):3932-6.
1979: Gilboa E; Mitra S W; Goff S; Baltimore D
A detailed model of reverse transcription and tests of crucial aspects.
Cell 1979;18(1):93-100.
1979: Mitra S W; Goff S; Gilboa E; Baltimore D
Synthesis of a 600-nucleotide-long plus-strand DNA by virions of Moloney murine leukemia virus.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(9):4355-9.
1979: Gilboa E; Goff S; Shields A; Yoshimura F; Mitra S; Baltimore D
In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus.
Cell 1979;16(4):863-74.
1979: Baltimore D; Gilboa E; Rothenberg E; Yoshimura F
Production of a discrete, infectious, double-stranded DNA by reverse transcription in virions of Moloney murine leukemia virus.
Cold Spring Harbor symposia on quantitative biology 1979;43 Pt 2():869-74.
1978: Groner Y; Gilboa E; Aviv H
Methylation and capping of RNA polymerase II primary transcripts by HeLa nuclear homogenates.
Biochemistry 1978;17(6):977-82.
1977: Gilboa E; Soreq H; Aviv H
Initiation of RNA synthesis in isolated nuclei.
European journal of biochemistry / FEBS 1977;77(2):393-400.
1977: Prives C; Gilboa E; Revel M; Winocour E
Cell-free translation of simian virus 40 early messenger RNA coding for viral T-antigen.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(2):457-61.
1976: Gilboa E; Aviv H
Preferential synthesis of viral late RNA by nuclei isolated from SV40 lytically infected cells.
Cell 1976;7(4):567-73.
1975: Prives C; Gilboa E; Aviv H; Revel M; Winocour E
Proceedings: Purification and translation of mRNA coding for SV40 proteins.
Israel journal of medical sciences 1975;11(11):1206.
1975: Gilboa E; Prives C L; Aviv H
Purification of SV-40 messenger RNA by hybridization to SV-40 DNA covalently bound to Sepharose.
Biochemistry 1975;14(19):4215-20.
1975: Prives C L; Aviv H; Gilboa E; Revel M; Winocour E
The cell-free translation of SV40 messenger RNA.
Cold Spring Harbor symposia on quantitative biology 1975;39 Pt 1():309-16.
1973: Gilboa E; Elkana Y; Rigbi M
Purification and properties of human acrosin.
European journal of biochemistry / FEBS 1973;39(1):85-92.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Eli Gilboa

Research Profile (preview)

Living Beings

Physiology

Anatomy

Chemicals & Drugs

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Eli Gilboa (preview)

All Publications